TipRanks
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie, McLaren Racing announce partnership
The FlyAbbVie, McLaren Racing announce partnership
5h ago
ABBV
AbbVie reports ABBV-466 trial meets primary endpoint
PremiumThe Fly
AbbVie reports ABBV-466 trial meets primary endpoint
1d ago
ABBV
AbbVie announces new, updated data from solid tumor portfolio at ESMO 2026
PremiumThe Fly
AbbVie announces new, updated data from solid tumor portfolio at ESMO 2026
2d ago
ABBV
AbbVie presents 20 scientific abstracts from its IBD portfolio
PremiumThe Fly
AbbVie presents 20 scientific abstracts from its IBD portfolio
2d ago
ABBV
AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO
PremiumMarket News
AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO
5d ago
C
IAM
AbbVie’s ABBV-1042 Trial Update: Early Pipeline Data That Matters for Investors
PremiumCompany AnnouncementsAbbVie’s ABBV-1042 Trial Update: Early Pipeline Data That Matters for Investors
5d ago
ABBV
AbbVie presents new AFFIRM study data
Premium
The Fly
AbbVie presents new AFFIRM study data
7d ago
ABBV
AbbVie Targets Head and Neck Cancer With New Telisotuzumab Combo Trial
Premium
Company Announcements
AbbVie Targets Head and Neck Cancer With New Telisotuzumab Combo Trial
7d ago
ABBV
AbbVie announces presentation of 22 scientific abstracts from IBD portfolio
PremiumThe Fly
AbbVie announces presentation of 22 scientific abstracts from IBD portfolio
9d ago
ABBV
The Week That Was, The Week Ahead: Macro and Markets, October 11
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, October 11
9d ago
C
T
Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look
PremiumMarket News
Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look
11d ago
JNJ
MDT
AbbVie price target raised to $275 from $260 at UBS
PremiumThe Fly
AbbVie price target raised to $275 from $260 at UBS
11d ago
ABBV
AbbVie price target raised to $305 from $289 at BofA
PremiumThe FlyAbbVie price target raised to $305 from $289 at BofA
11d ago
ABBV
AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study
Premium
Company Announcements
AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study
12d ago
ABBV
AbbVie price target raised to $300 from $285 at JPMorgan
Premium
The Fly
AbbVie price target raised to $300 from $285 at JPMorgan
12d ago
ABBV
AbbVie price target raised to $290 from $285 at Cantor Fitzgerald
PremiumThe Fly
AbbVie price target raised to $290 from $285 at Cantor Fitzgerald
12d ago
ABBV
3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List
PremiumMarket News
3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List
13d ago
ABT
JNJ
AbbVie price target raised to $310 from $296 at Morgan Stanley
PremiumThe Fly
AbbVie price target raised to $310 from $296 at Morgan Stanley
13d ago
ABBV
AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations
PremiumThe Fly
AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations
13d ago
ABBV
AbbVie price target raised to $320 from $280 at Scotiabank
PremiumThe FlyAbbVie price target raised to $320 from $280 at Scotiabank
14d ago
ABBV
AbbVie sees Q3 EPS $3.73-$3.77, consensus $3.84
Premium
The Fly
AbbVie sees Q3 EPS $3.73-$3.77, consensus $3.84
15d ago
ABBV
AbbVie sees FY26 EPS $13.76-$13.96, consensus $14.01
Premium
The Fly
AbbVie sees FY26 EPS $13.76-$13.96, consensus $14.01
15d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >